Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epacadostat and Pembrolizumab in Gastric and GEJ Adenocarcinoma
NCT03196232Phase 2Completed
- Start
- Sep 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of epacadostat in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, esophageal adenocarcinoma (EAC). Started Sep 2017; status: completed.
02
Drugs
epacadostat
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinomaesophageal adenocarcinoma (EAC)
Beyond the preview
Go deeper on NCT03196232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03196232.